AGS Therapeutics
PrivateLast Round
Accelerator
May 30, 2023
Company Overview
AGS Therapeutics operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was an Accelerator round in May 2023.
AGS Therapeutics is a biotechnology company that utilizes the natural machinery of microalgae to develop therapeutics such as mRNA, RNAi, proteins and peptides, delivered by microalgae extracellular vesicles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AGS Therapeutics Comparables
Compare AGS Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ciloa | 83% | |
| Carmine Therapeutics | 82% | |
| Carus Bio | 81% |
For institutional investors. Book with your work email.
AGS Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 30, 2023 | ||||
| Series A | Dec 14, 2022 | ||||
| Grant | Jul 7, 2022 | ||||
| Pre Seed | Sep 7, 2021 |
For institutional investors. Book with your work email.
AGS Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of France | Grant |
| Spartners by Servier & BioLabs | Accelerator |
| Bpifrance | Grant, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 30, 2023
Received funding from Sparners by Servier & BioLabs.
- Dec 14, 2022
$32M round closed.
For institutional investors. Book with your work email.
AGS Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AGS Therapeutics's valuation, stock price, and market status.
Is AGS Therapeutics a public or private company?
AGS Therapeutics is a private company.
What is the current stock price of AGS Therapeutics?
AGS Therapeutics is a private company, so its shares have no public market price. Caplight tracks AGS Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AGS Therapeutics worth (valuation)?
Valuation information for AGS Therapeutics is not publicly available.
Can I buy AGS Therapeutics stock?
AGS Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AGS Therapeutics's last funding round?
AGS Therapeutics's most recent funding round was Accelerator on May 30, 2023.
Who are the main investors in AGS Therapeutics?
Key investors in AGS Therapeutics include Government of France, Spartners by Servier & BioLabs, Bpifrance.
Will AGS Therapeutics IPO soon?
No public IPO plans have been announced for AGS Therapeutics.
How can I track AGS Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in AGS Therapeutics's shares on secondary markets.